Hahn Capital Management LLC lessened its holdings in Agilent Technologies, Inc. (NYSE:A – Free Report) by 33.7% during the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 47,691 shares of the medical research company’s stock after selling 24,260 shares during the quarter. Agilent Technologies makes up 4.6% of Hahn Capital Management LLC’s holdings, making the stock its 5th largest holding. Hahn Capital Management LLC’s holdings in Agilent Technologies were worth $7,081,000 as of its most recent SEC filing.
A number of other hedge funds and other institutional investors have also bought and sold shares of A. Crewe Advisors LLC increased its stake in Agilent Technologies by 114.8% in the second quarter. Crewe Advisors LLC now owns 189 shares of the medical research company’s stock worth $25,000 after purchasing an additional 101 shares during the period. Livelsberger Financial Advisory purchased a new stake in Agilent Technologies in the third quarter worth $28,000. Ridgewood Investments LLC purchased a new stake in Agilent Technologies in the second quarter worth $29,000. Ashton Thomas Private Wealth LLC purchased a new stake in Agilent Technologies in the second quarter worth $39,000. Finally, Larson Financial Group LLC increased its stake in shares of Agilent Technologies by 29,300.0% during the first quarter. Larson Financial Group LLC now owns 294 shares of the medical research company’s stock valued at $43,000 after buying an additional 293 shares during the period. Hedge funds and other institutional investors own 87.42% of the company’s stock.
Agilent Technologies Price Performance
Shares of NYSE A opened at $130.72 on Friday. The company has a debt-to-equity ratio of 0.36, a quick ratio of 1.37 and a current ratio of 1.78. The company has a market cap of $38.14 billion, a PE ratio of 30.90, a P/E/G ratio of 6.96 and a beta of 1.05. The business has a 50-day simple moving average of $140.91 and a two-hundred day simple moving average of $138.59. Agilent Technologies, Inc. has a fifty-two week low of $96.80 and a fifty-two week high of $155.35.
Agilent Technologies Dividend Announcement
The company also recently announced a quarterly dividend, which was paid on Wednesday, October 23rd. Investors of record on Tuesday, October 1st were issued a dividend of $0.236 per share. This represents a $0.94 dividend on an annualized basis and a dividend yield of 0.72%. The ex-dividend date of this dividend was Tuesday, October 1st. Agilent Technologies’s dividend payout ratio (DPR) is 22.22%.
Insider Activity at Agilent Technologies
In other news, CEO Padraig Mcdonnell sold 1,958 shares of the stock in a transaction on Thursday, August 22nd. The shares were sold at an average price of $145.00, for a total value of $283,910.00. Following the sale, the chief executive officer now owns 24,118 shares in the company, valued at $3,497,110. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. In other news, CEO Padraig Mcdonnell sold 1,958 shares of the business’s stock in a transaction dated Thursday, August 22nd. The stock was sold at an average price of $145.00, for a total value of $283,910.00. Following the completion of the transaction, the chief executive officer now owns 24,118 shares of the company’s stock, valued at $3,497,110. The trade was a 0.00 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, SVP Dominique Grau sold 9,990 shares of the firm’s stock in a transaction dated Thursday, September 26th. The stock was sold at an average price of $145.00, for a total value of $1,448,550.00. Following the sale, the senior vice president now directly owns 40,011 shares in the company, valued at approximately $5,801,595. This trade represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 11,995 shares of company stock worth $1,739,510 over the last quarter. Insiders own 0.33% of the company’s stock.
Wall Street Analysts Forecast Growth
Several brokerages have recently commented on A. UBS Group raised their price target on Agilent Technologies from $141.00 to $150.00 and gave the company a “neutral” rating in a research note on Thursday, August 22nd. Bank of America raised their price target on Agilent Technologies from $140.00 to $147.00 and gave the company a “neutral” rating in a research note on Thursday, August 22nd. Stifel Nicolaus restated a “buy” rating and set a $151.00 price target on shares of Agilent Technologies in a research note on Monday, August 26th. Evercore ISI raised their price target on Agilent Technologies from $135.00 to $145.00 and gave the company an “in-line” rating in a research note on Tuesday, October 1st. Finally, Wells Fargo & Company began coverage on Agilent Technologies in a research note on Tuesday, August 27th. They set an “overweight” rating and a $157.00 price target on the stock. One research analyst has rated the stock with a sell rating, five have issued a hold rating and nine have given a buy rating to the company’s stock. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of $144.36.
View Our Latest Stock Report on Agilent Technologies
About Agilent Technologies
Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.
Featured Articles
- Five stocks we like better than Agilent Technologies
- What is the Hang Seng index?
- Monopar Therapeutics Skyrockets 400% on Licensing Deal
- What are earnings reports?
- Tractor Supply Stock Pulls Back: A Prime Buying Opportunity
- 5 discounted opportunities for dividend growth investors
- The Downtrend in UPS Stock Isn’t Over Yet
Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies, Inc. (NYSE:A – Free Report).
Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.